APA (7th ed.) Citation

Westendorf, K., Žentelis, S., Wang, L., Foster, D., Vaillancourt, P., Wiggin, M., . . . Barnhart, B. C. (2022). LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Cell reports (Cambridge), 39(7), 110812. https://doi.org/10.1016/j.celrep.2022.110812

Chicago Style (17th ed.) Citation

Westendorf, Kathryn, et al. "LY-CoV1404 (bebtelovimab) Potently Neutralizes SARS-CoV-2 Variants." Cell Reports (Cambridge) 39, no. 7 (2022): 110812. https://doi.org/10.1016/j.celrep.2022.110812.

MLA (9th ed.) Citation

Westendorf, Kathryn, et al. "LY-CoV1404 (bebtelovimab) Potently Neutralizes SARS-CoV-2 Variants." Cell Reports (Cambridge), vol. 39, no. 7, 2022, p. 110812, https://doi.org/10.1016/j.celrep.2022.110812.